Lapteva and his colleagues have found that the proliferation rate of basal‐like breast cancer cells that inhibit CXCR4 expression by small interfering RNA technology is significantly lower than that of normal breast cancer cells, which provides direct evidence for the key role of CXCR4 in the growth of breast cancer cells.12 This evidence concerns the gene CXCR4 and breast carcinoma.